Tadalafil
- Product NDC
- 50268-738
- 11-digit product format
- 502680738
- Labeler code
- 50268
- Product ID
- 50268-738_df22addc-06e7-9804-e053-2a95a90a6c3f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA210069
- Marketing category
- ANDA
- Marketing start
- 2020-02-26
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-738 | TADALAFIL TABLET, FILM COATED [AVPAK] | 6 | Legacy NDC | 20250112_9f7dfabf-40dc-d433-e053-2a95a90ac784.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-738-13 | 50268073813 | 30 BLISTER PACK in 1 BOX (50268-738-13) > 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-738-11) | 30 blister pack | 2020-02-26 | 0000-00-00 | No | No | Current |